Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Otorhinolaryngology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    March 2024
  1. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    PubMed     Abstract available


    February 2024
  2. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    PubMed     Abstract available


  3. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    PubMed     Abstract available


  4. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    PubMed     Abstract available


    January 2024
  5. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    PubMed     Abstract available


    November 2023
  6. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    PubMed     Abstract available



  7. Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    PubMed    


    October 2023
  8. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    PubMed     Abstract available


    September 2023
  9. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    PubMed     Abstract available


  10. LEHTINEN M, Butt J, Gray P, Brenner N, et al
    HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.
    Int J Cancer. 2023;153:1313-1315.
    PubMed    


  11. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    PubMed     Abstract available


  12. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    PubMed     Abstract available


    June 2023
  13. SEO S, Keam B, Shin SH, Chae YS, et al
    A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
    Int J Cancer. 2023 Jun 26. doi: 10.1002/ijc.34622.
    PubMed     Abstract available


    May 2023
  14. ZHENG XH, Deng CM, Zhou T, Li XZ, et al
    Saliva biopsy: Detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2023 May 12. doi: 10.1002/ijc.34561.
    PubMed     Abstract available


    March 2023
  15. DU Y, Feng R, Chang ET, Yin L, et al
    Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: a population-based patient cohort study in southern China.
    Int J Cancer. 2023 Mar 25. doi: 10.1002/ijc.34524.
    PubMed     Abstract available


  16. ZHU X, Heng Y, Zhou J, Lin H, et al
    Time-varying association of Second Primary Malignancy and Long-term Survival Outcomes in Patients with Head and Neck Cancer.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34520.
    PubMed     Abstract available


  17. NGUYEN HT, Tang W, Webster ALH, Whiteaker JR, et al
    Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34506.
    PubMed     Abstract available


  18. ZHENG XH, Li XZ, Zhou T, Jiang CT, et al
    Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34491.
    PubMed     Abstract available


  19. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    PubMed     Abstract available


    February 2023
  20. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    PubMed     Abstract available


  21. SIMBA H, Menya D, Mmbaga BT, Dzamalala C, et al
    The contribution of smoking and smokeless tobacco to esophageal squamous cell carcinoma risk in the African esophageal cancer corridor: results from the ESCCAPE multicenter case-control studies.
    Int J Cancer. 2023 Feb 2. doi: 10.1002/ijc.34458.
    PubMed     Abstract available


    January 2023
  22. BUDHATHOKI S, Diergaarde B, Liu G, Olshan A, et al
    A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34444.
    PubMed     Abstract available


  23. SUZUKI H
    HPV hijacks enhancers to activate oncogenes in head and neck squamous cell carcinoma cells.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34440.
    PubMed    


  24. MIMA M, Okabe A, Hoshii T, Nakagawa T, et al
    Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34439.
    PubMed     Abstract available


  25. CARVAJAL LJ, Shing JZ, Vanegas JC, Gonzalez E, et al
    TRENDS IN INCIDENCE RATES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS OVERALL AND BY POTENTIAL RELATEDNESS TO HUMAN PAPILLOMAVIRUS, COSTA RICA 2006-2015.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34437.
    PubMed     Abstract available


    December 2022
  26. BOERNER T, Carr RA, Hsu M, Michel A, et al
    Incidence and Management of Esophageal Cancer Recurrence to Regional Lymph Nodes After Curative Esophagectomy.
    Int J Cancer. 2022 Dec 27. doi: 10.1002/ijc.34417.
    PubMed     Abstract available


    October 2022
  27. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    PubMed     Abstract available


  28. WANG Q, Xie H, Li Y, Theodoropoulos N, et al
    Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.
    Int J Cancer. 2022;151:1291-1303.
    PubMed     Abstract available


  29. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    PubMed     Abstract available


  30. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    PubMed     Abstract available


    September 2022
  31. ZHU H, Ma X, Ye T, Wang H, et al
    Esophageal cancer in China: practice and research in the new era.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34301.
    PubMed     Abstract available


  32. POELL JB, Wils LJ, Brink A, Dietrich R, et al
    Oral cancer prediction by noninvasive genetic screening.
    Int J Cancer. 2022 Sep 7. doi: 10.1002/ijc.34277.
    PubMed     Abstract available


    August 2022
  33. GHOLAP D, Dikshit R, Chaturvedi P, Chaturvedi AK, et al
    Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34258.
    PubMed     Abstract available


  34. AN L, Zheng R, Zeng H, Zhang S, et al
    The survival of esophageal cancer by subtype in China with comparison to the United States.
    Int J Cancer. 2022 Aug 1. doi: 10.1002/ijc.34232.
    PubMed     Abstract available


    July 2022
  35. NOMBURG J, Bullman S, Nasrollahzadeh D, Collisson EA, et al
    An international report on bacterial communities in esophageal squamous cell carcinoma.
    Int J Cancer. 2022 Jul 15. doi: 10.1002/ijc.34212.
    PubMed     Abstract available


    June 2022
  36. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available


    April 2022
  37. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available


  38. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available


    March 2022
  39. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available


  40. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available


    February 2022
  41. ANTONSSON A, de Souza MMA, Panizza BJ, Whiteman DC, et al
    Sexual debut and association with oral HPV infection, persistence and oropharyngeal cancer - an analysis of two Australian cohorts.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33986.
    PubMed     Abstract available


  42. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available


  43. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.
    PubMed    


  44. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available


    December 2021
  45. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available


    November 2021
  46. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available


    September 2021
  47. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.